Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance
- 1 December 2015
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 339 (2) , 333-341
Abstract
No abstract availableKeywords
Funding Information
- Griffth University
- Menzies Health Institute of Queensland
- School of Medical Science
This publication has 51 references indexed in Scilit:
- Regulation of microRNA‐1288 in colorectal cancer: Altered expression and its clinicopathological significanceMolecular Carcinogenesis, 2013
- Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLCPLOS ONE, 2013
- The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancerBMC Cancer, 2012
- Tumor suppressor p53 meets microRNAsJournal of Molecular Cell Biology, 2011
- Prognostic significance of differentially expressed miRNAs in esophageal cancerInternational Journal of Cancer, 2010
- MicroRNAs in colorectal cancer: translation of molecular biology into clinical applicationMolecular Cancer, 2009
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008
- MicroRNA-126 Regulates HOXA9 by Binding to the HomeoboxMolecular and Cellular Biology, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- MicroRNA—implications for cancerVirchows Archiv, 2007